Every story as it publishes, newest first.
A newly public biotech is betting its entire future on a single antibody platform designed to silence the cytokine scientists call the itch cytokine, and its pipeline already stretches from skin disease into inflammatory…
A retired couple converted $95,000 to a Roth IRA thinking they controlled the timing of their tax bill. They did not account for the letter Social Security will mail in November.
Tesla just posted record deliveries and a massive revenue beat while simultaneously cratering its own earnings and flipping free cash flow negative. Wall Street's 47 analysts cannot agree on what that contradiction means, and…
Every president inherits the national debt, but some have added to it at a pace that dwarfs their predecessors. The ranking of who grew it fastest may surprise you, cutting across party lines and…
Wall Street is pricing Alphabet like a company losing the AI race, but a quiet milestone suggests the market may be making a very expensive mistake.
Wall Street's most dominant process control chipmaker just dropped nearly 10% in a month despite a five-quarter beat streak, and one high-conviction analyst sees a gap forming that the rest of the Street has…
Turning 55 with a thin retirement balance feels like arriving late to a race with no shortcut, but three ETFs are quietly becoming the go-to toolkit for savers who need growth, income, and damage…
Daniel Loeb just made Warner Bros. Discovery his largest new position, exiting Nvidia and Broadcom to fund it. Here is what billionaires see that most analysts are still missing.
The market keeps pricing Oracle like a legacy database company, but the numbers underneath tell a completely different story about where enterprise AI infrastructure is actually being built.
XRP's crowd sentiment just hit its most bearish reading in three months, and contrarians say that alone makes it a buy. But the on-chain data tells a more complicated story.
While Wall Street obsesses over AI darlings, four familiar dividend stocks have quietly built yields as high as 6.8% and sit at entry points that income investors may soon regret ignoring.
Bill Ackman once fled Netflix at a loss, so his decision to buy back in now raises a pointed question: does he see a genuine turnaround forming in a stock that has badly lagged…
A new rule now forces high earners to send their catch-up contributions somewhere they may not want them to go, and the choice between a Roth workplace plan and a taxable brokerage account carries…
Wall Street kicked off the week with a flurry of bold calls on some of the market's most closely watched names, and at least one stock just scored a target price hike of more…
McDonald's has shed nearly 15% from its recent peak while a bold analyst just raised his target to levels most of Wall Street won't touch, and the question isn't whether the fundamentals support a…
